Home' Australian Pharmacist : Australian Pharmacist October 2016 Contents Australian Pharmacist October 2016 I ©Pharmaceutical Society of Australia Ltd.
CONTINUING PROFESSIONAL DEVELOPMENT
6. Cohen S, Mikuls TR. Initial treatment of rheumatoid arthritis in
adults. In: UpToDate. 2016. At: www.uptodate.com/contents/
7. Rheumatology Expert Group. Rheumatology, version 2.
Melbourne: Therapeutic Guidelines; 2010.
8. Moreland LW, Cannella A. General principles of management
of rheumatoid arthritis in adults. In: UpToDate. 2016. At: www.
9. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral
density changes during the menopause transition in a
multiethnic cohort of women. J Clin Endocrinol Metab
2008;93(3):861–8 . At: www.ncbi.nlm.nih.gov/pmc/articles/
10. Australian Rheumatology Association. Patient information
on prednisolone and prednisone; 2016. At: https://
11. Rossi S, ed. Australian medicines handbook. Adelaide:
Australian Medicines Handbook; 2016.
12. Endocrinology Expert Group. Endocrinology, version 5.
Melbourne: Therapeutic Guidelines; 2014.
13. Osteoporosis Australia. Bone density testing in general
practice; 2014. At: www.osteoporosis.org.au/sites/default/
14. Ehrenfeld M, Schoenfeld Y. Hematological manifestations of
rheumatoid arthritis. In UpToDate. 2016. At: www.uptodate.
1. Which ONE of the following
statements regarding methotrexate
is the MOST appropriate?
a) Methotrexate can be given as
monotherapy in the setting of early
b) Methotrexate is rarely beneficial for
preventing progression to erosive
definitive rheumatoid arthritis (RA).
c) Methotrexate should not be used when
the anti-cyclic citrullinated peptide
(anti-CCP) is positive.
d) Methotrexate no longer requires
concomitant treatment with folic acid.
2. With regards to using non-steroidal
anti-inflammatory drugs (NSAIDs) in
rheumatoid arthritis (RA), which ONE
of the following is INCORRECT?
a) NSAIDs are an effective therapy for
improving the symptoms of RA.
b) NSAIDs do not reduce joint damage.
c) Patients with RA are at increased
risk of developing peptic ulcers, and
consideration should be given to testing
for Helicobacter pylori infection before
d) NSAIDs are a useful treatment option for
older patients with renal impairment.
3. Which ONE of the following
statements regarding rheumatoid
arthritis (RA) is INCORRECT?
a) RA is more common in those aged
55 years and older.
b) RA affects women 1.6 times more than
c) RA is an acute autoimmune disease that
occurs in approximately 2.5% of the
d) RA is associated with increased
mortality, particularly in older women.
4. Which ONE of the following
statements regarding the
complications of rheumatoid arthritis
(RA) is the MOST appropriate?
a) Smoking improves responses to RA
b) Systemic inflammation in RA is likely the
main contributor to the increased risk of
c) Exercise should be avoided, as this will
increase disease activity in RA.
d) Exercise can improve psychological,
but not physical, function in patients
of naproxen and concomitant ACE
inhibitor use, in order to ensure renal
function has not been compromised,
and to monitor for hyperkalaemia.
3. Monitor blood pressure given there
has been an increase in naproxen
dosage and a need for low-dose
4. Recommend the GP aim for short-term
use of high-dose naproxen and low-
dose prednisolone if possible, reducing
dose as soon as the flare is controlled,
or while waiting for effect of second
DMARD, depending upon the outcome
of the rheumatologist review.
5. Encourage Regina to trial regular
paracetamol as an adjunct to pain
relief and potentially reduce the need
for an NSAID.
6. Consider cholesterol testing – especially
as this patient is over 45 years of age,
and given RA patients are at a higher risk
of cardiovascular disease.
7. Consider measuring BMD given the
need for intermittent corticosteroids,
RA and post-menopause status.
8. Consider iron studies as well as FBC,
given fatigue may be exacerbated by
an increased risk of anaemia of chronic
disease and/or iron-deficiency anaemia.
1. Australian Institute of Health and Welfare. A snapshot of
rheumatoid arthritis. Bulletin no. 116 . Cat. no. AUS 171.
Canberra: AIHW; 2013. At: www.aihw.gov.au/WorkArea/
2. Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet
3. Rubbert-Roth A, Finckh A. Treatment options in patients with
rheumatoid arthritis failing initial TNF inhibitor therapy: a
critical review. Arthritis Res Ther 2009;11(Suppl 1):S1.
4. Gabriel SE, Crowson CS, Kremers HM, et al. Survival in
rheumatoid arthritis: a population-based analysis of trends
over 40 years. Arthritis Rheum 2003;48(1):54–8 .
5. Mikuls TR, Saag KG, Criswell LA, . Mortality risk associated with
rheumatoid arthritis in a prospective cohort of older women:
results from the Iowa Women’s Health Study. Ann Rheum Dis
Australian Pharmacist Continuing Professional
Development (CPD) is a central element of PSA’s
CPD & PI program.
The CPD section is recognised under the PSA
CPD & PI program as a Group 2 activity. Members
can choose which articles they want to answer
questions on and get CPD credits based on the
questions they answer.
CPD credits are allocated based on the length of
the article and the complexity of the information
presented. A minimum of 6 out of 8 questions, 4 out
of 5 questions, or 3 out of 4 questions correct is
required for the allocation of Group 2 CPD credits.
PSA members can answer online at www.psa.org.au.
Login to submit your answers online. If you
do not have member access details, you can
request them via a link from the login page.
• Select 'Professional development and assessment'
• Select 'Submit answers'
• Select 'Australian Pharmacist'
Submit your answers online before
1 December 2016 at www.psa.org.au
and receive automatic feedback.
Links Archive Australian Pharmacist September 2016 Australian Pharmacist November 2016 Navigation Previous Page Next Page